» Articles » PMID: 12663785

Kinetics of CD4+ and CD8+ Memory T-cell Responses During Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees

Overview
Journal J Virol
Date 2003 Mar 29
PMID 12663785
Citations 79
Authors
Affiliations
Soon will be listed here.
Abstract

The immunological correlates of hepatitis C virus (HCV)-specific immunity are not well understood. Antibodies to HCV structural proteins do not appear to play a key role in clearance of the virus and do not persist after recovery. Here, we studied the kinetics of the cellular immune responses of three HCV-recovered chimpanzees during rechallenge with increasing doses of homologous HCV. Although HCV envelope antibodies remained undetectable throughout the rechallenge, all animals mounted rapid HCV-specific T-cell responses. The pattern of the cellular immune response in blood and liver correlated with the virological outcome. The animal that most rapidly cleared circulating HCV as determined by nested reverse transcription-PCR (RT-PCR) displayed the most vigorous and sustained response of gamma interferon (IFN-gamma)-producing and proliferating CD4(+) T cells in the blood. Vigorous CD4(+) T-cell proliferation during viremia was followed by an increased frequency and a phenotypic and functional change of the tetramer(+) CD8(+) T-cell population. The second animal cleared HCV initially with strong peripheral and intrahepatic CD4(+) T-cell responses but experienced low-level HCV recrudescence 12 weeks later, when HCV-specific T cells became undetectable. The third animal maintained minute amounts of circulating HCV, detectable only by nested RT-PCR, in the face of a weak IFN-gamma(+) T-cell response. Collectively, the results suggest protective rather than sterilizing immunity after recovery from hepatitis C. The rate of HCV clearance following reexposure depends on the cellular immune response, the quality and quantity of which may vary among chimpanzees that recovered from HCV infection.

Citing Articles

Development of a Multiple-Epitope-Based Vaccine for Hepatitis C Virus Genotypes 1a and 1b: an in-silico reverse vaccinology approach.

Das E, Samantaray M, Abrol K, Basumatari J, Pushan S, Ramaswamy A In Silico Pharmacol. 2024; 12(2):100.

PMID: 39524457 PMC: 11549267. DOI: 10.1007/s40203-024-00275-4.


Chronic HCV infection promotes cytotoxicity in antigen-specific CD8 T cells regardless of virus specificity.

Maretti-Mira A, Salomon M, Hsu A, Matsuba C, Golden-Mason L Front Virol. 2023; 3.

PMID: 37886042 PMC: 10601542. DOI: 10.3389/fviro.2023.1198361.


Factors Associated with Spontaneous Clearance of Recently Acquired Hepatitis C Virus among HIV-Positive Men in Brazil.

Ferrufino R, Rodrigues C, Figueiredo G, Gleison D, Yapura S, de Matos M Viruses. 2023; 15(2).

PMID: 36851529 PMC: 9958744. DOI: 10.3390/v15020314.


Serum neutralization activity declines but memory B cells persist after cure of chronic hepatitis C.

Nishio A, Hasan S, Park H, Park N, Salas J, Salinas E Nat Commun. 2022; 13(1):5446.

PMID: 36114169 PMC: 9481596. DOI: 10.1038/s41467-022-33035-z.


Immune Mechanisms Underlying Hepatitis B Surface Antigen Seroclearance in Chronic Hepatitis B Patients With Viral Coinfection.

Wu S, Yi W, Gao Y, Deng W, Bi X, Lin Y Front Immunol. 2022; 13:893512.

PMID: 35634301 PMC: 9130599. DOI: 10.3389/fimmu.2022.893512.


References
1.
Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A . Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999; 401(6754):708-12. DOI: 10.1038/44385. View

2.
Major M, Mihalik K, Fernandez J, Seidman J, Kleiner D, Kolykhalov A . Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus. J Virol. 1999; 73(4):3317-25. PMC: 104096. DOI: 10.1128/JVI.73.4.3317-3325.1999. View

3.
Kolykhalov A, Mihalik K, Feinstone S, Rice C . Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo. J Virol. 2000; 74(4):2046-51. PMC: 111684. DOI: 10.1128/jvi.74.4.2046-2051.2000. View

4.
Lechner F, Wong D, Dunbar P, Chapman R, Chung R, Dohrenwend P . Analysis of successful immune responses in persons infected with hepatitis C virus. J Exp Med. 2000; 191(9):1499-512. PMC: 2213430. DOI: 10.1084/jem.191.9.1499. View

5.
Takaki A, Wiese M, Maertens G, Depla E, Seifert U, Liebetrau A . Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med. 2000; 6(5):578-82. DOI: 10.1038/75063. View